Get Bilag Questionnaire

The BILAG index is an ordinal scale index that assesses 8 systems (general, mucocutaneous, neuropsychiatric, musculoskeletal, cardiorespiratory, vasculitis, renal, and hematologic) (3). It was developed based on the principle of physician's intention to treat.

The British Isles Lupus Assessment Group (BILAG) index is a standardized systemic lupus erythematosus (SLE) disease activity assessment. The main aim of this study was to correlate the BILAG index with laboratory measures of disease activity in childhood-onset SLE with and without biopsy-proven lupus nephritis. Method.

Farr assay, has been used to monitor global disease activity and SLE renal involvement (4–7). However, because associations with disease characteristics are at best modest, clinicians and researchers still lack reliable biomarkers of SLE activity (4–7).

Objectives: The BILAG index is a clinical measure of lupus disease activity. It is valid, reliable and sensitive to change. Scoring in the BILAG index is based upon the physician's intention to treat. A flare of active lupus is defined as a new A or B score in at least one system.

Each system is assigned a disease activity grade, ranging from A to E. Grade A represents very active disease requiring immunosuppressive drugs and/or dose of >20 mg daily (or equivalent). Grade B represents moderate disease activity requiring a lower dose of corticosteroids, anti-malarials or NSAIDs.

Easy-BILAG is novel template for recording BILAG-2004 disease activity assessments in systemic lupus erythematosus (SLE). It has been designed to assist clinicians complete disease activity assessments using the established instrument, the BILAG-2004 index, more quickly and accurately in routine clinical practice.

The British Isles Lupus Assessment Group (BILAG) index is a standardized systemic lupus erythematosus (SLE) disease activity assessment. The main aim of this study was to correlate the BILAG index with laboratory measures of disease activity in childhood-onset SLE with and without biopsy-proven lupus nephritis. Method.

In conclusion, the BILAG-2004 index is sensitive to change. It is suitable for use in longitudinal studies of SLE if the outcome of interest is worsening of disease activity or major improvement in disease activity to low level of activity.